A pregnant patient, currently at 10 weeks of gestation, presents to her obstetrician complaining of worsening vaginal discomfort over the past five days. She describes persistent vulvovaginal pruritus and a copious, foul-smelling, yellow-green discharge. She has no abdominal pain, fever, or chills. On pelvic examination, the vulva is edematous and erythematous. The cervix exhibits patchy macular erythema. The vaginal pH is 6.2. Wet mount preparation of the discharge reveals abundant polymorphonuclear leukocytes and motile, flagellated protozoa. Which of the following is the most appropriate next step in management?
- Initiate therapy with oral metronidazoleCevap
- BInitiate therapy with intravaginal metronidazole
- CDefer therapy until the second trimester of pregnancy
- DInitiate therapy with oral azithromycin
- EInitiate therapy with intravaginal clotrimazole
Cevap
The correct answer is to initiate therapy with oral metronidazole.
The correct answer is to initiate therapy with oral metronidazole. The patient's presentation of a frothy, yellow-green discharge, a 'strawberry cervix' (patchy macular erythema), a vaginal pH greater than 4.5, and motile, flagellated organisms on wet mount is strictly diagnostic of Trichomonas vaginalis. Because T. vaginalis infects the Skene and Bartholin glands as well as the urethra, systemic therapy with oral metronidazole is required for a complete cure. Despite historical concerns regarding early pregnancy, oral metronidazole is currently considered safe and is recommended during all trimesters of pregnancy to relieve maternal symptoms and mitigate the risk of premature rupture of membranes and preterm birth.
Adım Adım Çözüm
Anahtar Kavram
Management of Trichomonas vaginalis in the first trimester of pregnancy